前列腺癌根治术后放疗10年以上生活质量变化
本研究对181例根治性前列腺切除术后接受三维适形放疗的患者,用EPIC问卷在放疗前、放疗最后一天及放疗后2个月、1–3年、6–9年、10–13年多次评估生活质量。结果显示放疗5年后泌尿、肠道和性功能领域生活质量显著下降,年龄和治疗反应是重要影响因素。
要点
- 放疗后6–9年和10–13年,泌尿困扰、尿失禁困扰和肠道困扰评分较基线显著下降。
- 年龄<68岁与≥68岁患者相比,长期泌尿困扰和尿失禁困扰差异随时间增大。
- PSA未下降者和较高直肠剂量与更差的长期肠道或泌尿困扰相关。
核心结论
- 与放疗后最初几年的早期评估不同,放疗5年后泌尿、肠道和性功能领域生活质量显著下降。
- 年龄增长可能是主要因素,年轻且对治疗有反应的患者长期生活质量结果最有利。
研究设计与样本
- 回顾性分析2003–2008年接受术后三维适形放疗、1.8–2.0 Gy分次至66.0–66.6 Gy的181例前列腺癌根治术后患者。
- 使用EPIC问卷在放疗前、放疗最后一天、放疗后2个月、1–3年、6–9年和10–13年进行生活质量调查。
主要发现
- 放疗后6–9年和10–13年,泌尿困扰、尿失禁困扰和肠道困扰评分较基线变化分别为13、14、7分和14、15、7分(所有比较P<.01)。
- 性功能评分平均下降6分和8分(P<.01)。
- 年龄<68岁与≥68岁患者相比,放疗后1–3年泌尿困扰变化为0 vs 7分、尿失禁困扰为0 vs 7分;放疗后10–13年为8 vs 23分和6 vs 35分。
- PSA未下降者10年以上泌尿困扰变化25 vs 12(P=.04)、尿失禁困扰36 vs 10(P=.03)、肠道困扰20 vs 5(P=.07)。
- 较高直肠剂量与更大急性和长期肠道困扰评分下降相关,膀胱剂量与生活质量变化无相关性。
临床怎么用
- 对根治术后放疗患者应长期随访泌尿、肠道和性功能生活质量,尤其关注年龄较大者。
- 关注PSA反应和直肠剂量,可能有助于识别长期生活质量下降风险较高的患者。
局限性
- 本研究使用三维适形放疗,作者指出调强放疗概念可能改善结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To analyze long-term quality-of-life (QoL) changes related to postoperative radiation therapy (RT) after radical prostatectomy. METHODS AND MATERIALS: Patients who received postoperative 3-dimensional conformal RT in the years 2003 to 2008 with 1.8 to 2.0 Gy fractions up to 66.0 to 66.6 Gy (n = 181) were surveyed using the Expanded Prostate Cancer Index Composite questionnaire before the beginning of RT (A); on the last day (B); and 2 months (C), 1 to 3 years (D), 6 to 9 years (E), and 10 to 13 years (F) after RT. RESULTS: Mean urinary bother, urinary incontinence bother, and bowel bother score changes (in relation to baseline at time A) of 13, 14, and 7 and 14, 15, and 7 were found at times E and F, respectively (P < .01 for all comparisons). Sexual function scores decreased 6 and 8 points on average (P < .01). Patient age at the time of RT had a considerable impact on urinary bother and urinary incontinence bother, with increasing differences over time when comparing patients aged <68 versus ≥68 years: 0 versus 7 and 0 versus 7 points at time D and 8 versus 23 and 6 versus 35 points at time F, respectively. Patients who did not respond to RT with a decreasing prostate-specific antigen level had greater urinary and urinary incontinence bother and bowel bother score changes >10 years after treatment (25 vs 12; P = .04, 36 vs 10; P = .03, and 20 vs 5; P = .07, respectively). A higher rectal dose was associated with greater acute and long-term bowel bother score decrease. No correlation was found between the dose to the bladder and QoL changes. CONCLUSIONS: In contrast to early evaluations in the first years, significantly decreasing QoL in the urinary, bowel, and sexual domains was found >5 years after RT. Aging is likely to be a major factor. Younger patients who responded to the treatment had the most favorable long-term QoL results. As 3-dimensional conformal RT was used in this study, intensity modulated concepts could result in improved outcomes.
引用
- Leufgens F, Berneking V, Vögeli TA, et al. Quality of Life Changes >10 Years After Postoperative Radiation Therapy After Radical Prostatectomy for Prostate Cancer. Int J Radiat Oncol Biol Phys. 2019. PMID: 31201895. doi:10.1016/j.ijrobp.2019.06.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。